| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000034560 |
| Receipt No. | R000039399 |
| Scientific Title | A prospective observational study to investigate the effect of rehabilitation for cancer patients in palliative care units in Japan: a pilot-feasibility study |
| Date of disclosure of the study information | 2018/10/18 |
| Last modified on | 2019/11/18 (Ver. 6) |
| Basic information | ||
| Public title | A prospective observational study to investigate the effect of rehabilitation for cancer patients in palliative care units in Japan: a pilot-feasibility study
|
|
| Acronym | A prospective observational study to investigate the effect of rehabilitation for cancer patients in palliative care units in Japan: a pilot-feasibility study
|
|
| Scientific Title | A prospective observational study to investigate the effect of rehabilitation for cancer patients in palliative care units in Japan: a pilot-feasibility study
|
|
| Scientific Title:Acronym | A prospective observational study to investigate the effect of rehabilitation for cancer patients in palliative care units in Japan: a pilot-feasibility study
|
|
| Region |
|
|
| Condition | ||
| Condition | Terminal stage cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The primary aim of this study is to determine whether it is feasible to conduct an international study of the evaluation of the effectiveness of rehabilitation for terminally ill cancer patients. |
| Basic objectives2 | Others |
| Basic objectives -Others | Feasibility |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Proportion of patients whose mBI can be evaluated at 3 weeks from baseline in each country and in each site |
| Key secondary outcomes | 1) Patient accrual per month in each country and in each site
2) Proportion of patients whose measurements can be evaluated at baseline in each country and in each site 3) Proportion of patients whose measurements can be evaluated at 1/2/3 weeks from baseline in each country and in each site 4) Proportion of patients whose clinical outcomes can be evaluated at 30 days follow-up in each country and in each site 5) Proportion of mortality at 30 days follow-up in each country and in each site 6) Average days from admission to referral rehabilitation in each country and in each site 7) Contents of rehabilitation 8) Change of mBI total score and sub 10 scores from baseline to 3 weeks or discharge or withdrawal 9) Change of PPS from baseline to 3 weeks or discharge or withdrawal 10) Change of ECOG PS from baseline to 3 weeks or discharge or withdrawal 11) Differences of change of mBI, PPS and ECOG PS from baseline to 3 weeks or discharge or withdrawal between patients who received rehabilitation and patients who did not receive rehabilitation 12) Proportion of adverse events or incidents which are possibly related to rehabilitation |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Life expectancy to be more than 3 weeks (PPI<6.0)
Age>18 years Cancer diagnosis(no treatment with curative intent) Hospitalized in PCU(only initial hospitalization of PCU) ECOG PS=2-4 |
|||
| Key exclusion criteria | Severe symptom burden (any of STAS 3 items (Pain control/Other symptom control/Patient anxiety) = score 4)
Severe cognitive impairment (cannot recognize a therapist) Respite admission (admission term is about within 1-2 weeks) |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Ashiya Municipal Hospital
|
||||||
| Division name | Rehabilitation | ||||||
| Zip code | 6598502 | ||||||
| Address | 39-1, Asahigaoka-cho Ashiya, Hyogo | ||||||
| TEL | 0797-31-2156 | ||||||
| nishiyama-nnk@umin.org | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Ashiya Municipal Hospital | ||||||
| Division name | Rehabilitation | ||||||
| Zip code | 6598502 | ||||||
| Address | 39-1, Asahigaoka-cho Ashiya, Hyogo | ||||||
| TEL | 0797-31-2156 | ||||||
| Homepage URL | |||||||
| nishiyama-nnk@umin.org | |||||||
| Sponsor | |
| Institute | Ashiya Municipal Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Policy-based medical services foundation |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ashiya municipal hospital |
| Address | 39-1, Asahigaoka-cho Ashiya, Hyogo |
| Tel | 0797312156 |
| nishiyama-nnk@umin.org | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | JORTC-RHB01 |
| Org. issuing International ID_1 | JORTC |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 市立芦屋病院(兵庫県)
ガラシア病院(大阪府) JCHO東京新宿メディカルセンター(東京都) 埼玉医科大学附属病院(埼玉県) 相良病院(鹿児島県) 甲南病院(兵庫県) 大阪赤十字病院(大阪府) 薬師山病院(京都府) 市立岸和田市民病院(大阪府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Study design: Procpective, observational study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039399 |